Emerging Immunotherapy Options for Metastatic NSCLC – OncLive
OncLive |
Emerging Immunotherapy Options for Metastatic NSCLC
OncLive I'm not sure we will reach really better data giving only immunotherapy checkpoint inhibitors. But then you have combination of checkpoints plus chemotherapy, and you have the combination of checkpoint and checkpoint, so CTLA-4 and anti-PD-1 or anti-PD … |
